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 Glaucoma and optic nerve (ON) trauma may lead to op-
tic nerve injury. It is widely known that central nervous sys-
tem (CNS) neurons fail to regenerate after injury. This ques-
tion has attracted intense investigation at both the preclinical
and clinical levels. Regeneration failure has been attributed in
part to proteins associated with CNS myelin and the scar that
forms at an injury site. Furthermore, an ON trauma model can
also be used as experimental research model to study CNS
injury.
Nogo-A, Nogo-B, and Nogo-C are major protein species
in oligodendrocytes and expressed in ON [1]. Among them,
Nogo-A is the principal protein that prevents axonal outgrowth.
A 66-amino loop structure located between two transmem-
brane domains named Nogo-66, which is common to all Nogo
forms, is the main contributor to this inhibitory effect. Nogo-
66 is expressed on the surface of oligodendrocytes [2] and
functions by binding to an axonal Nogo-66 receptor (NgR)
[3]. Nogo-66 is somewhat “fastidious” as regards to which
environment it will express, as it is expressed in the myelin of
a sciatic nerve transplant to the CNS but not in those to the
peripheral nervous system (PNS). This feature, together with
its in vitro activities, has confirmed Nogo-66 as a myelin-de-
rived inhibitor to the axonal regeneration after injury.
Kim et al. [4] found that corticospinal axons of young
adult Nogo-A knockout mice sprout extensively rostral to a
transection after spinal cord injury. In this study we investi-
gated axonal regeneration after optic nerve injury in young
adult Nogo-A/B/C knockout mice.
METHODS
Reagents:  Sodium pentobarbital, paraformaldehyde (Shang-
hai Biologic Company, Shanghai, China), Vectashield mount-
ing medium (H-1000, Vector Laboratories, Burlington,
Ontario, Canada), GAP-43 antibody (Serotec, Raleigh, NC),
DMEM medium and B-27 medium (Gibco, Burlington, CA),
Hanks solution (Hyclone, Logan, UT), papain (Worthington,
Lakewood, New Jersey), poly-lysine, bovine serum albumin,
DNAase, Thy1.1 antibody, phosphate buffer (Sigma, St. Louis,
MO), 5% goat serum (Zhongshan Company, Beijing, China),
SABC (Boster Company, Wuhan, China).
Equipment:  Equipment included: surgical microscope
(OMS-110, Topcon, Tokyo, Japan), 40 g power ON forceps
(Martins Instruments, Tullingen, Germany, donated by Pro-
fessor Gu Zhao-bin, Gifu University of Japan), anatomical
microscope (SZ-PT, Olympus, Tokyo, Japan), fluorescence
microscope (IX70, Olympus), optic microscope (Olympus),
CO2 incubator (BB16HF, Heal Force, Hong Kong, China),
ultraclean work table (D8C-010; Heal Force), incubation plate
(Coster Company, Cambridge, MA).
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Purpose: The axonal regeneration of retinal ganglion cells (RGCs) after optic nerve (ON) crush was investigated both in
vivo and in vitro on Nogo-A/B/C knockout mice.
Methods: The study used 20 Nogo-A/B/C knockout mice in the experimental group, and 20 C57BL/6 mice in the control
group. Partial ON injury was induced by using a specially designed ON clip to pinch the ON 1 mm behind the mouse
eyeball with 40 g pressure for 9 s. The left ON was injured in both groups, but the right ON was left untouched in the
control group. Nogo-A/B/C mRNA was studied by in situ hybridization in both groups. GAP-43 was studied by immun-
ofluorescence staining on frozen sections. RGCs were purified and cultured in DMEM medium containing B-27. Cells
were then immunostained with both Thy1.1 and GAP-43 antibodies. The axonal growth of RGCs was calculated by a
computerized image analyzer.
Results: GAP-43 expression was significantly higher in the experimental group than in the control group (p<0.01). GAP-
43 antibody binding was demonstrated in the axons of cultured RGCs. Axonal growth was significantly more active at
every observed time point in the experimental group than in the control group (F=43.25, 32.16; p<0.01).
Conclusions: Nogo genes play an inhibitive role in the axonal regeneration after ON injury, while Nogo-knockout is an
effective way to eliminate this inhibition and accelerate axonal regeneration.
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268Generation and maintenance of Nogo-A/B/C knockout
mutant mice:  A Nogo-targeted embryonic stem cell clone was
identified from the Omnibank sequence Tag database.
Omnibank mutations were created, using insertional mutagen-
esis based on retroviral-based gene trap methodology. Het-
erozygotic mice harboring the disrupted allele were bred to
C57Bl/6 mice for expansion in our animal housing facility
and intercrossed to maintain the Nogo-A/B/C mutation on a
hybrid 129SvEvBrd_C57Bl/6 background. The heterozygotic
mice (9 or 12-week-old) were donated by Professor Xiulan
Xu. The mice were raised in the laminar air flow cage rack
(Suzhou Experimental Equipment Company, Suzhou, China).
In the present study, animals were backcrossed to C57Bl/6 for
three to six generations, and 7-14-week-old Nogo-A/B/C-/-/-
littermates were used as controls for all experiments. The
present investigation adhered to the principles regarding the
care and use of animals according to the American Physiologic
Society, the Society for Neuroscience, and the ARVO State-
ment for the use of animals in ophthalmic and vision research.
Animal grouping:  The present study used 20 Nogo-A/B/
C knockout mice (8 or 12-week-old) in the experimental group,
and 20 C 57BL/6 control mice(8 or 12-week-old) in the con-
trol group. To depict the axonal growth at successive time
points, both groups were further divided into three subgroups
representing the first day (n=7), third day (n=7), and seventh
day (n=7) outcomes, respectively.
Surgical procedure:  Prior to ON crush, general anesthe-
sia was induced in each animal with an intraperitoneal injec-
tion of 1% sodium pentobarbital solution (50 mg/kg body
weight). A surgical microscope was used to visualize the ON,
which was exposed through a superior temporal approach. A
1-1.5 cm incision was made in the skin above the right orbit.
The dural sheath of the ON was opened longitudinally, from
which the ON was then gently detached before it was crushed
at 1 mm distal to the eyeball by an ON forceps with 40 g
pressure for 9 s. Injury to the ophthalmic artery was carefully
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Figure 1. Expression of Nogo-A/B/C
mRNA in optic nerve.  Expression of
Nogo-A/B/C mRNA in optic nerve of
experimental group (Nogo-A/B/C knock-
out mice) and control group (C57BL/6
mice) as visualized by in situ hybridiza-
tion stained as yellow. Positvie area of
stain of Nogo-A/B/C expression of ex-
perimental group was 1.36±0.05x102 µm2
whereas that of control group was
26.56±1.25x102 µm2. There was signifi-
cant difference positvie area of stain of
Nogo-A/B/C expression between experi-
mental group and control group(p<0.01).
A: Little or no expression of Nogo-A/B/
C mRNA was observed in the ON of
Nogo-A/B/C-knockout mice. B: Expres-
sion of Nogo-A/B/C mRNA was demon-
strated in the ON of young adult normal
mice. The scale bars represents 20 µm.
C: The crush position (arrow) of optic
nerve of experimental group (Nogo-A/B/
C knockout mice) can be investigated
under normal light microscopy. The scale
bars represent 20 µm. D: The crush posi-
tion (arrow) of optic nerve of control
group(C57BL/6 control mice) can be in-
vestigated under normal light micros-
copy. The scale bars represent 20 µm.
269avoided during the procedure. Nerve injury was verified by
the appearance of a clearing at the crush site; the vascular in-
tegrity of the retina was verified by funduscopic examination
after dilating the pupil with atropine. The left ON was crushed
in both groups, but the right ON was left untouched in the
control group.
Preparation for pathological and immunohistochemistry
examinations:  Seven days after ON crush, thoracotomy was
performed. The animals were perfused through the heart with
heparin saline followed by 4% paraformaldehyde, including
diethypyrocarbonate (DEPC) for in situ hybridization. Eyes
with ON segments up to the optic chiasm were postfixed over-
night, and transferred to a 30% sucrose solution overnight (4
°C) and including DEPC for in situ hybridization overnight (4
°C). Frozen sections (15 µm) were cut longitudinally on a cry-
ostat, thaw mounted onto coated glass slides, and stored at -
80 °C until further use.
Digoxygenin-labeled sense and antisense RNA probes
were generated as described [5]. The serial number (NM-
57142) and cDNA array of Nogo gene was achieved from
GenBank. The probe was designed with Primer 3 software
(Whitehead Institute for Biomedical Research, Cambridge,
MA). The common probe, recognizing all three isoforms of
Nogo, contains transcript A sequence between nucleotides 2535
and 4678.
Cryostat sections (15 µm) were mounted on Superfrost-
Plus slides. Sections were post-fixed in 4% paraformaldehyde
and PBS, acetylated in 0.1 M triethanolamine and 0.25% ace-
tic anhydride, and permeabilized for 20 min in 1% Triton X-
100 and PBS. Hybridization was performed overnight in 5x300
mM NaCl, 30 mM sodium citrate, pH 7.0 (SSC) buffer con-
taining 50% formamide and 2% blocking reagent at 68 °C.
Two rigorous washes were performed in 0.2X SSC at the same
temperature for 1 h, and signals were detected with alkaline
phosphatase-coupled anti-digoxigenin antibodies using
spreptavidin-biotin-peroxidase complex (SABC) as color re-
action substrates.
Immunofluorescence staining:  GAP-43 monoclonal an-
tibody (1:500 dilution) was used in all cases. Secondary anti-
bodies conjugated to distinct fluorescence (1:500 fluorescein-
conjugated anti-sheep IgG) were used, and coverslipped with
antifade medium.
Isolation and culture of retinal ganglion cells:  The eyes
of the mice were collected after they were given a lethal dose
of sodium pentobarbital. Retinas were isolated and dissected
under an anatomic microscope to remove visible vessels be-
fore they were washed three times in Hank’s balanced salt
solution.
RGCs from the retina were isolated and purified as previ-
ously described [6,7]. Briefly, the retinal tissue was dissoci-
ated into single cells in Eagle’s minimum essential medium
that contained 15 U/ml papain and 70 U/ml collagenase. The
cell suspension was incubated successively in a polypropy-
lene tube coated with a monoclonal anti-rat macrophage IgG
to remove macrophages, and then in another one coated with
a monoclonal anti-rat Thy 1.1 IgG. Finally, the tube was gen-
tly washed five times with PBS. RGCs were collected by cen-
trifugation at 700xg for 5 min and then cultured at a concen-
tration of 6x106 cells/ml in DMEM that contained 100 U/ml
penicillin, 100 µg/ml gentamicin, and B-27. Cells were then
seeded into poly-lysine coated 24-well plates and incubated
at 37 °C with 5% CO2 ventilation. Half of the medium was
renewed with cytarbine (20 µg/ml) added at certain intervals.
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Figure 2. Expression of GAP-43 in experimental group (Nogo-A/B/
C knockout mice) and control group (C57BL/6 mice; GAP-43 stain).
A: There is more expression of GAP-43 in experimental group (green
fluorescence stain). Regenerated axon can be investigated under im-
munofluorescence microscope. There was significant difference in
stained positive areas on the ON sections between experimental group
(Nogo-A/B/C knockout mice) and control groups (C57BL/6 control
mice). B: There is less expression of GAP-43 in the control group
(GAP-43 stain). The scale bars represent 20 µm.
TABLE 1. STAINED POSITIVE AREA OF EXPERIMENTAL AND CONTROL
GROUPS (MEAN±SD)
         Positive area of      Positive area of
             stain of             stain of
Time    experimental group   experimental group
(day)       (102µm2)             (102µm2)          t      p
-----   ------------------   ------------------   ----   -----
  1       5.06±0.26             0.36±0.05*         2.59  <0.01
  3       16.28±1.29            0.52±0.09          3.12  <0.01
  7       26.32±2.56**          0.88±0.25**        3.95  <0.01
          F                     45.36              2.85  <0.01
          p                     <0.01             <0.005
There was significant difference in stained positive areas on the ON
sections between experimental(Nogo-A/B/C knockout mice) and
control groups (C57BL/6 control mice). The positive area of GAP-
43 stain of the experimental group increased significantly from one
day to seven days after crush. There was little increase of the posi-
tive area of GAP-43 stain of the control group. Comparison at first
post-injury day, *p<0.01; comparison at seventh day,
**p<0.01.(asterisk means positive area of stain of experimental group
and control group at first post-injury day, double asterisk means posi-
tive area of stain of experimental group and control group at seventh
day).
270Cells were examined daily under phase-contrast microscope.
Immunocytochemistry:  RGCs were fixed in 4% paraform-
aldehyde for 15 min and blocked with 5% goat serum. After
three washes with PBS, the cells were incubated successively
with primary antibody anti-GAP-43 (1:1000) at 4 °C for 24 h,
secondary antibody goat-anti-rabbit IgG at 37 °C for 1 h, and
SABC at 37 °C for 30 min. Between each step, cells were
washed three times with PBS. After coloration with DAB,
dehydration, and dimethyl benzene treatment, slides were
mounted and examined with phase-contrast microscopy.
Statistical analysis:  The data were analyzed by the two-
tailed Student t-test, using software (Origin ver. 6.0, OriginLab
Corp., Northampton, MA).
RESULTS
 Expression of Nogo-A/B/C was in the cytoplasm of oligo-
dendrocytes of optic nerve which arrange like a line of pearl.
Stain of brown indicates positive expression of Nogo-A/B/C.
Expression of Nogo-A/B/C was calculated using image analy-
sis software. The images were taken using a digital camera
mounted on a microscope. The analysis was performed using
Image-Pro Plus version 4.0 (Media Cybernetics, Silver Spring,
MD). Positvie area of stain of Nogo-A/B/C expression of ex-
perimental group was 1.36±0.05x102µm/m2, whereas that of
control group was 26.56±1.25x102µm/m2. There was signifi-
cant difference positvie area of stain of Nogo-A/B/C expres-
sion between experimental group and control group (p<0.01).
Little or no expression of Nogo-A/B/C mRNA was observed
in the ON of Nogo-A/B/C-knockout mice (Figure 1A). Ex-
pression of Nogo-A/B/C mRNA was demonstrated in the ON
of young adult normal mice (Figure 1B).
GAP-43 is located in the regenerative axon of neurite.
Expression of GAP-43 stained with green fluorescence in Fig-
ure 2A,B indicates regeneration of axon of optic nerve. Axon
of positive GAP-43 expression distributes along the longitu-
dinal axis of optic nerve. GAP-43 expression of optic nerve
increased significantly with the survival time.
There was a significant difference in the size of the areas
that stained positively for GAP-43 on the ON sections be-
tween experimental(Nogo-A/B/C knockout mice) and control
groups (C57BL/6 control mice; p<0.01; Table 1). The posi-
tive area of GAP-43 stain of the experimental group increased
significantly from one day to seven days after crush. There
was little increase of the positive area of GAP-43 stain of the
control group.
In vitro axonal growth of the experimental and control
groups:  Adherence of RGCs began at 12 h after they were
seeded into poly-lysine- coated 24-well plates and incubated
at 37 °C 5% CO2 ventilation, and finished in 24 h. After this, a
single layer of round and oval RGCs was seen on the plates.
We investigated axonal generation by staining of GAP-
43. Axonal length was longer in the third day for the experi-
mental group (Nogo-A/B/C knockout mice; Figure 3A) than
that of the control group (C57BL/6 control mice) of the same
day (Figure 3B).
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Figure 3. Axonal length of cultured RGCs.  Axonal length of cul-
tured RGCs of experimental group (Nogo-A/B/C knockout mice)
and control group (C57BL/6 control mice) in the third day. The RGCs
were purified and cultured as described above. The body of RGCs is
round or oval. The RGCs were stained with GAP-43 antibody. The
regenerative axon was stained as yellow. A: Axonal length was longer
in the third day for the experimental group (Nogo-A/B/C knockout
mice). B: Axonal length of the control group (C57BL/6 control mice)
of the same day.(datas can be seen in Table 2). The scale bars repre-
sent 40 µm (GAP-43 stain).
TABLE 2. AXONAL LENGTH OF RETINAL GANGLION CELLS OF DIFFERENT
TIME (Μ Μ Μ Μ ΜM MEAN±SD)
Culture
 time
 (day)    Experimental group   Control group     t       p
-------   ------------------   -------------   -----   -----
  1         2.63±1.35            2.52±1.32     0.96    >0.05
  3         23.39±5.56           9.32±2.24     3.26    <0.01
  7         13.32±3.12           6.15±2.36     3.15    <0.01
            F                    43.25         32.16
            p                    <0.01         <0.01
The difference in axonal length between experimental group (Nogo-
A/B/C knockout mice) increased from the first day to seventh day
after crush. The axonal length of control group (C57BL/6 control
mice) increased from the first day to third day, then descreased from
the third day to seventh day. The difference in axonal length between
experimental group (Nogo-A/B/C knockout mice) and control group
(C57BL/6 control mice) was not significant (*p>0.05) on the first
postoperative day. However, the difference in axonal length was sig-
nificant by the third and seventh days between experimental group
and control group.
271Axonal length was calculated using image analysis soft-
ware. The images were taken using a digital camera mounted
on a microscope. For neurite length determinations, the neurites
were traced and the morphometry analysis was performed
using Image-Pro Plus version 4.0 (Media Cybernetics, Silver
Spring, MD). The length of the axon was defined as the dis-
tance from the soma to the tip of the process. An average of 50
neurons from each group was selected from a number of cham-
ber slides. The difference in axonal length of the experimental
group (Nogo-A/B/C knockout mice) increased from the first
day to the seventh day after crush. The axonal length of the
control group (C57BL/6 control mice) increased from the first
day to the third day, then decreased from the third day to the
seventh day. The difference in axonal length between the ex-
perimental group (Nogo-A/B/C knockout mice) and the con-
trol group (C57BL/6 control mice) was not significant (p>0.05)
on the first postoperative day. However, the difference in ax-
onal length became obvious by the third and seventh days
between the experimental and control groups. (p<0.01; Table
2).
DISCUSSION
 Several myelin inhibitors of axon growth, including NogoA
[2,8,9], myelin-associated glycoprotein [10], and oligodendro-
cyte-myelin glycoprotein [11], exert their effects through the
Nogo receptor, and p75 [3].
The Nogo gene has been cloned and its product appears
to be a new member of the reticulon family [12]. An extracel-
lular segment composed of 66 amino acid residues between
two transmembrane domains, known as Nogo-66, is the ma-
jor functional domain of this protein [3].
A neutralizing monoclonal antibody, neurite outgrowth
inhibitor 1 (IN-1), has recently been confirmed to target the
N-terminal domain of Nogo-A encoded by exon 3 [13]. When
IN-1 is applied to several CNS injury models, including spi-
nal cord lesions and cortical lesions, there is notable neuroana-
tomical and behavioral recovery compared with controls [14].
These results suggest that the Nogo-NgR system is account-
able for, to a large degree, the inhibitory activity that is re-
sponsible for the prevention of CNS axonal regeneration after
injury.
Increased expression of Nogo-A in RGCs after ON in-
jury indicates that Nogo-A may play an inhibitory role in ax-
onal regeneration after ON injury.
The expressed GAP-43 is located in the growth cone of
the regenerating axon. Positive expression of GAP-43 in our
figures indicate regeneration of axon of optic neve.
There was a significant difference in the area of ON stained
positive for GAP-43 between the experimental group(Nogo-
A/B/C knockout mice) and the control group(C57BL/6 mice)
in this study. Nogo is important inhibitor for regeneration af-
ter CNS injury. Knockout of Nogo-A/B/C gene can lead to
regeneration after optic nerve injury in this study. The results
indicate that Nogo-A/B/C plays an important role in the inhi-
bition of axonal regeneration after ON injury.
The significant difference in the length of axons regener-
ated in vitro between the experimental and control groups on
the third and seventh postoperative days suggests that Nogo-
A/B/C elimination is effective in enhancing axonal regenera-
tion of RGCs in at least in vitro experiments.
The analysis on mice with various degrees of gene dis-
ruption targeted at Nogo isoforms has been reported by three
groups. Kim et al. [11] observed significant corticospinal tract
fiber sprouting in young Nogo-A/B-/- mice compared with wild-
type and Nogo-A/B+/- mice. Simonen et al. [15] noted moder-
ate corticospinal tract fiber regeneration in Nogo-A-/- mice.
However, Zheng et al. [16] saw no significant regeneration in
either Nogo-A/B-/- line or Nogo-A/B/C-/- line mice above that
of wild type. It is believed that the varying degrees of regen-
erative capacity after Nogo elimination can be attributed to
the differences in genetic backgrounds of the mice used in the
experiments [17].
Increased expression of Nogo-A in RGCs after ON in-
jury indicates that Nogo-A may play an inhibitory role in ax-
onal regeneration after ON injury.
There was a significant difference in the area of ON stained
positive for GAP-43 between the experimental group and the
control group in this study. The expressed GAP-43 is located
in the growth cone of the regenerating axon. The results indi-
cate that Nogo-A/B/C plays an important role in the inhibi-
tion of axonal regeneration after ON injury.
The significant difference in the length of axons regener-
ated in vitro between the experimental and control groups on
the third and seventh postoperative days suggests that Nogo-
A/B/C elimination is effective in enhancing axonal regenera-
tion of RGCs in at least in vitro experiments.
Several myelin inhibitors of axonal growth, including
Nogo-66, myelin-associated glycoprotein, and oligodendro-
cyte-myelin glycoprotein, exert their effects through NgR.
Further investigation of NgR may reveal whether NgR gene
knockout enhances axonal regeneration after ON injury even
more effectively.
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